Efficacy and safety of rituximab as second-line therapy in immune thrombocytopenic purpura based on ethnicity: A descriptive study among the Arabic population

por Ata, Fateen, Yousaf, Zohaib, Zahir, Fathima Z., Mohamed Babiker, Anas, Ali Farooqi, Amer, Ahmad Al Hiyari, Mousa, Al Bozom, Adel Issam, Mohamed, Ahmed Hatim., Nashwan, Abdulqadir J., Yassin, Mohamed A.
Publicado 2022